PRKAA1 and diabetes mellitus: Similarly, baseline AMPK activity, a critical determinant of metformin sensitivity, is often impaired in patients with diabetes owing to persistent metabolic stress, potentially affecting the predictive value of AMPK-related biomarkers [12].